Year: 2023

Bexmarilimab monotherapy shows efficacy in achieving disease control and prolonged survival in late-stage metastatic solid tumors CLEVER-1 targeting is safe and well-tolerated with no serious adverse effects Bexmarilimab induced macrophage activation and increased IFNɣ signaling in patients who achieved disease control and prolonged survivalTURKU, Finland and BOSTON, Dec. 07, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company pioneering macrophage reprogramming for effective anticancer immunotherapies, today announces the publication of the full safety and anti-tumor efficacy results from the first-in-human Phase 1/2 MATINS trial of bexmarilimab in patients with treatment-refractory late-stage solid tumors in Cell Reports Medicine. The publication, entitled,...

VANCOUVER, British Columbia, Dec. 07, 2023 (GLOBE NEWSWIRE) — Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on its South Crofty Tin Project (“South Crofty” or the “Project”) in Cornwall, United Kingdom, is pleased to provide an update on the progress of dewatering of South Crofty Mine. Mine Dewatering Tracking Ahead of ExpectationsDewatering has been underway since early November with up to 25,000m3 per day of water pumped directly from South Crofty Mine and treated at the Water Treatment Plant (“WTP”); Treated water is being discharged into the Red River which is having a positive effect on the water quality of the river downstream of the discharge point; The water discharged from South Crofty Mine powers a 75 kW hydro-turbine located ahead of...

Falcon Oil & Gas Ltd.(“Falcon”) Successful Completion of SS1H Stimulation Program 7 December 2023 – Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to announce the completion of the 10-stage stimulation program over a 500 metre horizontal section of the Amungee Member B-Shale within the Shenandoah South 1H (“SS1H”) well in EP117 which is operated by Falcon Oil & Gas Australia Limited’s joint venture partner, Tamboran B2 Pty Limited (“Tamboran”). Details are as follows:The stimulation program at SS1H delivered a proppant intensity of 2,212 pounds per foot (lb/ft) and average proppant injection per stage was 356,000 pounds.The stimulation program achieved rates of 100 barrels per minute (bpm) using slickwater, a first in the Amungee Member B-Shale and in-line with current US shale basin stimulation designs.Tamboran...

Hexagon Purus awarded purchase order by Ford Trucks to deliver a hydrogen fuel storage system for their prototype heavy-duty truckFord Truck’s Fuel Cell Electric-Powered Vehicle (FCEV) F-MAX. Credit: Ford Trucks(Oslo, 7 December 2023) Hexagon Purus, a world leading supplier of zero-emission infrastructure and mobility solutions, has been awarded a purchase order by Ford Trucks to deliver a complete hydrogen fuel storage system for development of a Fuel Cell Electric-Powered Vehicle (FCEV) F-MAX as part of the Horizon Europe project ZEFES (Zero Emission Freight EcoSystem), a zero-emission logistics deployment project in which Ford Trucks participates with the vision of pioneering future transportation solutions. As a partner in project ZEFES, a pan-European project specifically targeting decarbonization of long-haul heavy-duty...

AB Akola Group (former AB Linas Agro Group), ISIN code LT0000128092 (hereinafter – the Company), received notification from UAB „SB Asset Management“ on the disposal of voting rights due to the increase in the authorized capital of the Company (enclosed).Additional information: Mažvydas Šileika, CFO of AB Akola Group Mob. +370 619 19 403 E-mail m.sileika@akolagroup.ltAttachmentNotification-of-disposal-of-block-of-shares LNA 2023 12 06-s1206

SOCIETE GENERALE SIGNS AGREEMENTS TO SELL TWO SUBSIDIARIES IN AFRICA TO VISTA GROUP Press releaseParis, 7 December 2023 Societe Generale has signed two agreements with Vista Group which plan the total divestment of Societe Generale group’s shares in its local African subsidiaries:   Société Générale Burkina Faso and Banco Société Générale Moçambique, currently owned at 52.6% and 65% respectively. According to the commitments made, the Vista Group would take over all activities operated by these subsidiaries, as well as all Societe Generale’s client portfolios and all employees within these entities. The completion of these transactions, which could take place in 2024, is subject to the approval of the entities’ governance bodies, the usual conditions precedent and the validation of the relevant financial and regulatory authorities. Press...

Jøtul AS (“Jøtul” or the “Company“) has mandated Pareto Securities AB to arrange a series of fixed income investor meetings commencing on 8 December 2023. Subject to, inter alia, market conditions, a 3-year senior secured floating rate bond issue in an initial amount of NOK 600 million under a framework of NOK 900 million may follow (the “Bond Issue“). The proceeds from the contemplated Bond Issue will be used to finance, inter alia, the redemption of the Company’s outstanding 2021/2024 bond loan (ISIN NO0011104069) including accrued and unpaid interest, refinance other existing debt, and to finance transaction costs and general corporate purposes. Jøtul also provides certain financial updates relating to the full year figures for 2023 and 2024. The Company expects to post net revenue and adjusted EBITDA of...

PRESS RELEASE7 December 2023EN – 20231207 – Renault Group – Press Release – Re Industry WITH RE-INDUSTRY, RENAULT GROUP IS LAUNCHING AN AMBITIOUS PLAN TO TRANSFORM ITS INDUSTRIAL BASE Renault Group is launching a plan to fundamentally transform its industrial base. Between now and 2027, it is seeking to cut production costs per vehicle by 30% for internal combustion vehicles and 50% for electric vehicles. Renault Group’s Industrial Metaverse will play a key role in the transformation, enabling the Group to accelerate its competitive advantage and reinvent vehicle production. Renault Group is increasing the agility of its industrial base and announcing the arrival of new models in its plants.Boulogne-Billancourt, 7 December 2023 – Renault Group has announced the launch of a plan for the in-depth...

PIVLAZ™, a new drug for prevention of Cerebral Vasospasm in patients with Aneurysmal Subarachnoid Hemorrhage (aSAH), approved in South Korea PIVLAZ will become commercially available in South Korea in early 2025Tokyo, Japan, Seoul, South Korea, and Cambridge, UK, 7 December 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) today announces that PIVLAZ™ (clazosentan sodium) 150 mg has received marketing approval from the Ministry of Food and Drug Safety (MFDS) in South Korea for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage (aSAH) securing. The MFDS approval is based on scientific and clinical data from an extensive Japanese Phase 3 program submitted by Idorsia Pharmaceuticals Korea (“IPK”),...

Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with newly diagnosed multiple myeloma not eligible for transplantSarclisa added to bortezomib, lenalidomide and dexamethasone (VRd) significantly reduced the risk of disease progression or death compared with VRd alone First global Phase 3 study to report positive results with an anti-CD38 therapy in combination with VRd in transplant-ineligible patients, reinforcing the potential for Sarclisa as a best-in-class medicine Study results will be submitted for presentation at an upcoming medical meeting and form the basis of a future regulatory submissionPARIS, December 7, 2023. The Phase 3 IMROZ trial evaluating the investigational use of Sarclisa® (isatuximab) in combination with standard-of-care bortezomib, lenalidomide and dexamethasone...